Centessa Pharmaceuticals plc (CNTA)
NASDAQ: CNTA · Real-Time Price · USD
24.85
0.00 (0.00%)
Dec 19, 2025, 4:00 PM EST - Market closed
Centessa Pharmaceuticals Analyst Ratings
Total Analysts
11
Consensus Rating
Strong Buy
Price Target
$37.70
Upside
+51.71%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Buy Maintains $40 → $62 | Buy | Maintains | $40 → $62 | +149.50% | Dec 10, 2025 |
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $33 → $42 | Strong Buy | Maintains | $33 → $42 | +69.01% | Dec 1, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $28 → $43 | Strong Buy | Maintains | $28 → $43 | +73.04% | Nov 18, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $30 → $35 | Buy | Maintains | $30 → $35 | +40.85% | Nov 13, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $31 → $30 | Buy | Maintains | $31 → $30 | +20.72% | Nov 7, 2025 |
| Stephens & Co. | Stephens & Co. | Buy Initiates $35 | Buy | Initiates | $35 | +40.85% | Oct 28, 2025 |
| Guggenheim | Guggenheim | Strong Buy Reiterates $28 | Strong Buy | Reiterates | $28 | +12.68% | Oct 6, 2025 |
| Wells Fargo | Wells Fargo | Buy Initiates $31 | Buy | Initiates | $31 | +24.75% | Sep 3, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $30 | Strong Buy | Maintains | $30 | +20.72% | Aug 12, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $30 | Strong Buy | Maintains | $30 | +20.72% | Jul 30, 2025 |
| Truist Securities | Truist Securities | Strong Buy Initiates $30 | Strong Buy | Initiates | $30 | +20.72% | Jul 21, 2025 |
| Needham | Needham | Strong Buy Initiates $35 | Strong Buy | Initiates | $35 | +40.85% | May 28, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Initiates $30 | Strong Buy | Initiates | $30 | +20.72% | May 8, 2025 |
| Piper Sandler | Piper Sandler | Buy Initiates $38 | Buy | Initiates | $38 | +52.92% | Mar 31, 2025 |
| Guggenheim | Guggenheim | Strong Buy Reiterates $28 | Strong Buy | Reiterates | $28 | +12.68% | Mar 26, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $27 | Buy | Initiates | $27 | +8.65% | Mar 7, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.